These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35810032)
21. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648 [TBL] [Abstract][Full Text] [Related]
22. Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients. Halbgebauer R; Halbgebauer S; Oeckl P; Steinacker P; Weihe E; Schafer MK; Roselli F; Gebhard F; Huber-Lang M; Otto M Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077033 [TBL] [Abstract][Full Text] [Related]
23. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury. Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802 [TBL] [Abstract][Full Text] [Related]
24. Plasma Neurofilament Light and Glial Fibrillary Acidic Protein Levels over Thirty Days in a Porcine Model of Traumatic Brain Injury. Shin SS; Hefti MM; Mazandi VM; Issadore DA; Meaney DF; Schneider ALC; Diaz-Arrastia R; Kilbaugh TJ J Neurotrauma; 2022 Jul; 39(13-14):935-943. PubMed ID: 35369719 [TBL] [Abstract][Full Text] [Related]
25. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. McMahon PJ; Panczykowski DM; Yue JK; Puccio AM; Inoue T; Sorani MD; Lingsma HF; Maas AI; Valadka AB; Yuh EL; Mukherjee P; Manley GT; Okonkwo DO; J Neurotrauma; 2015 Apr; 32(8):527-33. PubMed ID: 25264814 [TBL] [Abstract][Full Text] [Related]
26. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial. Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937 [TBL] [Abstract][Full Text] [Related]
27. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985 [TBL] [Abstract][Full Text] [Related]
28. Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma. Papa L; Zonfrillo MR; Ramirez J; Silvestri S; Giordano P; Braga CF; Tan CN; Ameli NJ; Lopez M; Mittal MK Acad Emerg Med; 2015 Nov; 22(11):1274-82. PubMed ID: 26469937 [TBL] [Abstract][Full Text] [Related]
29. Plasma extracellular vesicles as a source of biomarkers in traumatic brain injury. Puffer RC; Cumba Garcia LM; Himes BT; Jung MY; Meyer FB; Okonkwo DO; Parney IF J Neurosurg; 2020 Jul; 134(6):1921-1928. PubMed ID: 32707544 [TBL] [Abstract][Full Text] [Related]
30. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529 [TBL] [Abstract][Full Text] [Related]
31. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats. Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798 [TBL] [Abstract][Full Text] [Related]
32. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study. Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A; EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528 [TBL] [Abstract][Full Text] [Related]
33. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury. Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005 [TBL] [Abstract][Full Text] [Related]
34. GFAP positivity in neurons following traumatic brain injuries. Zwirner J; Lier J; Franke H; Hammer N; Matschke J; Trautz F; Tse R; Ondruschka B Int J Legal Med; 2021 Nov; 135(6):2323-2333. PubMed ID: 34114049 [TBL] [Abstract][Full Text] [Related]
35. Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury. Anderson TN; Hwang J; Munar M; Papa L; Hinson HE; Vaughan A; Rowell SE J Trauma Acute Care Surg; 2020 Jul; 89(1):80-86. PubMed ID: 32251265 [TBL] [Abstract][Full Text] [Related]
36. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury. Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225 [TBL] [Abstract][Full Text] [Related]